Intermittent regimens for tuberculosis treatment: Back to the Future?

Eur Respir J. 2020 Sep 3;56(3):2002510. doi: 10.1183/13993003.02510-2020. Print 2020 Sep.

Jan-Willem C Alffenaar^{1

2

3}, Simon Tiberi⁴, Daniela M Cirillo⁵, Giovanni Battista Migliori^{6

7}

¹ Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, Australia johannes.alffenaar@sydney.edu.au.
² Westmead Hospital, Sydney, Australia.
³ Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.
⁴ Dept of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
⁵ Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁶ Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
⁷ Blizard Institute, Queen Mary University of London, London, UK.

No abstract available

Publication types